Years of standing still have ended, and the field of nephrology has seen a plethora of clinical trials, changing the therapeutic landscape of chronic kidney disease (CKD) and immune-mediated kidney disease management [...].

Cambridge University Hospitals Addenbrooke's Hospital Hills Road Cambridge CB2 0QQ UK

Department of Medicine University of Cambridge Trinity Ln Cambridge CB2 1TN UK

Department of Nephrology 1st Faculty of Medicine General University Hospital Charles University U Nemocnice 2 128 08 Prague Czech Republic

Zobrazit více v PubMed

Van Daalen E.E., Wester Trejo M.A.C., Göçeroğlu A., Ferrario F., Joh K., Noël L.H., Ogawa Y., Wilhelmus S., Ball M.J., Honsova E., et al. Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis. Clin. J. Am. Soc. Nephrol. 2020;15:1103–1111. doi: 10.2215/CJN.14561119. PubMed DOI PMC

Kronbichler A., Jayne D.R.W. ANCA Renal Risk Score: Is prediction of end-stage renal disease at baseline possible? Kidney Int. 2018;94:1045–1047. doi: 10.1016/j.kint.2018.10.001. PubMed DOI

Malvar A., Alberton V., Lococo B., Ferrari M., Delgado P., Nagaraja H.N., Rovin B.H. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis. Kidney Int. 2020;97:156–162. doi: 10.1016/j.kint.2019.07.018. PubMed DOI

Bernardo-Bermejo S., Sánchez-López E., Tan L., Benito-Martínez S., Jiang Z., Castro-Puyana M., Lucio-Cazaña F.J., Marina M.L. Exploratory Metabolomic Analysis Based on Reversed-Phase Liquid Chromatography-Mass Spectrometry to Study an In Vitro Model of Hypoxia-Induced Metabolic Alterations in HK-2 Cells. Int. J. Mol. Sci. 2021;22:7399. doi: 10.3390/ijms22147399. PubMed DOI PMC

Casili G., Ardizzone A., Basilotta R., Lanza M., Filippone A., Paterniti I., Esposito E., Campolo M. The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia-Reperfusion. Int. J. Mol. Sci. 2021;22:1886. doi: 10.3390/ijms222111886. PubMed DOI PMC

Hwang S.H., Lee Y.M., Choi Y., Son H.E., Ryu J.Y., Na K.Y., Chin H.J., Jeon N.L., Kim S. Role of Human Primary Renal Fibroblast in TGF-β1-Mediated Fibrosis-Mimicking Devices. Int. J. Mol. Sci. 2021;22:758. doi: 10.3390/ijms221910758. PubMed DOI PMC

Sörensen-Zender I., Rong S., Haller H., Schmitt R. The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney Disease. Int. J. Mol. Sci. 2022;23:646. doi: 10.3390/ijms23020646. PubMed DOI PMC

Frydlova J., Zednikova I., Satrapova V., Pazourkova E., Santorova S., Hruskova Z., Tesar V., Vokurka M., Prikryl P., Korabecna M. Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis. Int. J. Mol. Sci. 2022;23:4344. doi: 10.3390/ijms23084344. PubMed DOI PMC

Leierer J., Perco P., Hofer B., Eder S., Dzien A., Kerschbaum J., Rudnicki M., Mayer G. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease. Int. J. Mol. Sci. 2021;22:6885. doi: 10.3390/ijms22136885. PubMed DOI PMC

Van Thiel B.S., van der Linden J., Ridwan Y., Garrelds I.M., Vermeij M., Clahsen-van Groningen M.C., Qadri F., Alenina N., Bader M., Roks A.J.M., et al. In Vivo Renin Activity Imaging in the Kidney of Progeroid. Int. J. Mol. Sci. 2021;22:2433. doi: 10.3390/ijms222212433. PubMed DOI PMC

Evgeniou M., Sacnun J.M., Kratochwill K., Perco P. A Meta-Analysis of Human Transcriptomics Data in the Context of Peritoneal Dialysis Identifies Novel Receptor-Ligand Interactions as Potential Therapeutic Targets. Int. J. Mol. Sci. 2021;22:3277. doi: 10.3390/ijms222413277. PubMed DOI PMC